The Safety of Adiponectin Receptor Agonist AdipoRon in a Rabbit Model of Arthrofibrosis-Reference-Cited by-同舟云学术

The Safety of Adiponectin Receptor Agonist AdipoRon in a Rabbit Model of Arthrofibrosis

Published:2023-04-01 Issue:4 Volume:29 Page:154-159
ISSN:1937-3384
Container-title:Tissue Engineering Part C: Methods
language:en
Short-container-title:Tissue Engineering Part C: Methods

Author:

Salmons Harold I.¹,Gow Christopher²,Limberg Afton K.¹,Bettencourt Jacob W.¹,Carstens Mason F.¹,Payne Ashley N.¹,Morrey Mark E.¹,Sanchez-Sotelo Joaquin¹,Berry Daniel J.¹,Dudakovic Amel¹,Abdel Matthew P.¹

Affiliation:

1. Department of Orthopedic Surgery and Mayo Clinic, Rochester, Minnesota, USA.

2. Department of Comparative Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Publisher

Mary Ann Liebert Inc

Subject

Biomedical Engineering,Medicine (miscellaneous),Bioengineering

Link

https://www.liebertpub.com/doi/pdf/10.1089/ten.tec.2023.0008

Reference32 articles.

1. Adiponectin Regulation and Function

2. Adiponectin Gene Is Expressed in Multiple Tissues in the Chicken: Food Deprivation Influences Adiponectin Messenger Ribonucleic Acid Expression

3. Protective effects of AdipoRon on the liver of Huoyan goose fed a high-fat diet

4. An Adiponectin Receptor Agonist Reduces Type 2 Diabetic Periodontitis

5. A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adiponectin Receptor Agonist AdipoRon Inhibits Proliferation and Drives Glycolytic Dependence in Non-Small-Cell Lung Cancer Cells;Cancers;2024-07-24

2. Efficacy of ADIPOR1 and ADIPOR2 peptide‐agonist AdipoRon in preventing contracture in a rabbit model of arthrofibrosis;Journal of Orthopaedic Research;2024-04-11

3. AdipoRon reduces TGFβ1‐mediated collagen deposition in vitro and alleviates knee stiffness in vivo;Journal of Cellular Physiology;2023-12-27

4. AdipoRon and ADP355, adiponectin receptor agonists, in Metabolic-associated Fatty Liver Disease (MAFLD) and Nonalcoholic Steatohepatitis (NASH): A systematic review;Biochemical Pharmacology;2023-12